Erratum: The efficacy and safety of anti-PD-1/PD-L1 antibodies combined with chemotherapy or CTLA4 antibody as a first-line treatment for advanced lung cancer.
| Autor: | Zhang B; Medical School of Nantong University, Nantong Shi, Jiangsu Sheng, People's Republic of China., Wu Q; Medical School of Nantong University, Nantong Shi, Jiangsu Sheng, People's Republic of China. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | International journal of cancer [Int J Cancer] 2019 Apr 01; Vol. 144 (7), pp. E2. Date of Electronic Publication: 2018 Dec 07. |
| DOI: | 10.1002/ijc.31820 |
| Databáze: | MEDLINE |
| Externí odkaz: |
|
Plný text